DR. TRAVIS JOHN OSTERMAN D.O.
Prescription History 1528295607
Internal Medicine - Hematology & Oncology in Nashville, TN
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. TRAVIS JOHN OSTERMAN D.O., an active Hematology & Oncology specialist practicing in Nashville, TN. Our medical registry currently tracks 2 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 35 documented patient claims. Among these therapy options, the most frequently utilized medication is Tagrisso, which accounts for 22 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2023)Rx (2023) | Avg Cost per FillCost / Fill | Vs. Other TN PrescribersVs. TN Avg |
|---|---|---|---|
| TagrissoOsimertinib Mesylate | 22 | $18,017.28 | ≈ Typical |
About Tagrisso: This medication is used to treat lung cancer. Show more ▾ Osimertinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal growth factor receptor-EGFR) in some tumors. In 2023, this provider wrote 22 Medicare prescriptions for Tagrisso, about 1.2 times the volume of the typical Tennessee prescriber of this medication (19). Medicare paid an average of $18,017.28 per fill, versus $16,179.42 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 22 30-Day Fills standardized to 30-day supplies 660 Days of Medication total across all patients in 2023 | |||
| RetevmoSelpercatinib | 13 | $23,870.95▼ below TN avg | ≈ Typical |
About Retevmo: This medication is used to treat certain types of cancer (such as lung cancer, thyroid cancer, medullary thyroid cancer, certain other solid tumors). Show more ▾ Selpercatinib belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. In 2023, this provider wrote 13 Medicare prescriptions for Retevmo, about the same volume as the typical Tennessee prescriber of this medication (12). Medicare paid an average of $23,870.95 per fill, versus $24,141.14 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average TN prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the TN average for this medication. 13 30-Day Fills standardized to 30-day supplies 390 Days of Medication total across all patients in 2023 | |||
About this data. The prescription history for DR. TRAVIS JOHN OSTERMAN D.O. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2023, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Hematology & Oncology prescribing approach at this Nashville, TN practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average volume among TN prescribers of the same medication. Always confirm current medications and costs directly with the provider and your plan.
